USPTO Official Slams Use Of Compulsory Patent Licenses

Law360, New York (June 27, 2012, 2:34 PM EDT) -- The deputy director of the U.S. Patent and Trademark Office on Wednesday blasted the use of compulsory patent licenses by certain countries, telling a congressional committee that many major pharmaceutical companies will delay bringing drugs to those countries because of the licenses.

“We are consistent on our efforts ... of trying to stop these compulsory licenses,” Teresa Stanek Rea, who is also the deputy undersecretary of commerce for intellectual property, told the House Judiciary Subcommittee on Intellectual Property, Competition and the Internet.

Compulsory licensing allows a...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.